Clinical trial
Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in…
NCT00001440 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00001440 |
|---|---|
| Title | Autologous T-Cell Transplantation and the Immunotherapy of Residual Disease in Breast Cancer: Pilot Study of Vaccine-Driven T-Cell Expansion in Patients Treated With Dose-Intensive Chemotherapy |
| Official title | Pilot Study of Autologous T Cells and/or IL-2 for the Enhancement of Immune Reconstitution After Dose-Intensive Chemotherapy for Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Breast Neoplasm, Neoplasm Metastasis |
| Intervention type | Drug, Procedure |
| Interventions | Autologous T cells, Interleukin-2 |
| Enrollment | 51 |
| Start date | Jul 1, 1995 |
| Completion | Jan 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: